Peter Kaiser

About Peter Kaiser

Prior to joining the Ocular Therapeutix management team, Peter K. Kaiser, MD, had been the Chief Medical Advisor – Retina since 2022. Dr. Kaiser graduated magna cum laude with Highest Honors from Harvard College and magna cum laude from Harvard Medical School. He completed an internal medicine internship at Massachusetts General Hospital, an ophthalmology residency at the Massachusetts Eye and Ear Infirmary, and a vitreoretinal fellowship at Bascom Palmer Eye Institute where he was a Heed Fellow before joining the vitreoretinal department of the Cole Eye Institute where he remains the Chaney Family Endowed Chair in Ophthalmology Research and Professor of Ophthalmology at the Cleveland Clinic Lerner College of Medicine and staff surgeon.Dr. Kaiser is actively involved in clinical research having served as Study Chairman for numerous major, multi-center, international clinical trials, and principal investigator in over 60 trials evaluating new treatments for AMD, DR, and other retinal disorders. He is the founding co-director of the Cole Eye Reading Center. Dr. Kaiser has been honored to receive the Lew R. Wasserman Award from the Research to Prevent Blindness and the Macula Society’s Young Investigator Award. He has been elected and previously served as the Retina Subspecialty Day Board Chairman for the American Academy of Ophthalmology Annual Meeting, as a member of the board of directors of the American Society of Retina Specialists (ASRS), and is a member of the Retina Society, Macula Society, EURETINA, and American Ophthalmological Society. He is a major contributor to the medical literature having authored 7 textbooks, over 30 book chapters, and more than 400 peer-reviewed manuscripts. Dr. Kaiser has been recognized by American Society of Retina Specialists Honor and Senior Honor Awards, along with the American Academy of Ophthalmology Achievement, Senior Achievement, and Lifetime Achievement Awards. He has been listed as one of the “Best Doctors in America” every year since 2002 and named one of the 150 Top Innovators in Retina by Ocular Surgery News, selected as a charter inductee of the Retina Hall of Fame in 2017, and appeared on The Ophthalmologist’s Power List 2018 and 2020 as one of the top 100 most influential people in the world of ophthalmology.

Experience

1. Member of Consulting Staff

   Cleveland Clinic

   Sep 2024 — Present

Education

• Harvard University

  Bachelor of Arts - BA, Neurobiology and Neurosciences